UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
We compare the top Sp 500 index funds by their expense ratios and total fees to help you locate the lowest-cost choice for retirement.
28,029 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...
Debt service now approaches $1 trillion annually as the interest on the $38.8 trillion national debt climbs, squeezin...
The Jets ETF has breached critical chart support, suggesting airline stocks face risks beyond rising fuel costs. Tech...
CrossCountry Mortgage pushes back in the bid for Two Harbors, saying a fully financed cash offer backed by Citi will ...
Caesars Entertainment moves to go private in a $17.6 billion deal, and investors are eyeing four lagging U.S. compani...
Strategy Inc. disclosed a fresh BTC purchase, increasing its digital asset reserve to 818,334 coins worth about $54 b...
XRP would need a dramatic rally and strong regulatory clarity to reach $20 this cycle. This report weighs the math, t...
XRP trades around $1.15 as Ripple builds regulatory momentum and broader adoption. Investors ask if the price underpl...
Hydrogen policy momentum and rising costs are shaping a wide range of outcomes for plug power (plug) stock, with anal...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...